Abstract
A series of substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl- and alpha-methyl-L-prolyl-phenylalanine derivatives was prepared as VLA-4/VCAM antagonists. The compounds showed excellent potency with a wide variety of neutral, polar, electron withdrawing or donating groups on the phenylalanine ring (IC50 approximately 1 nM). Heteroaryl ring substitution for phenylalanine was also well tolerated. Pharmacokinetic studies in rat were performed on a representative set of compounds in both series.
MeSH terms
-
Animals
-
Biological Availability
-
Dipeptides / chemical synthesis
-
Dipeptides / chemistry
-
Dipeptides / pharmacokinetics*
-
Dogs
-
Haplorhini
-
Inhibitory Concentration 50
-
Integrin alpha4beta1 / antagonists & inhibitors*
-
Metabolic Clearance Rate
-
Phenylalanine
-
Rats
-
Rats, Sprague-Dawley
-
Sheep
-
Structure-Activity Relationship
-
Sulfones
-
Vascular Cell Adhesion Molecule-1 / drug effects
Substances
-
Dipeptides
-
Integrin alpha4beta1
-
Sulfones
-
Vascular Cell Adhesion Molecule-1
-
Phenylalanine
-
benzenesulfonyl chloride